Last update 20 Mar 2025

Enterovirus Type 71 Vaccine(Hansenula Polymorpha)(Chongqing Bovax)

Overview

Basic Info

Drug Type
Prophylactic vaccine
Synonyms
Recombinant Enterovirus 71 vaccine(Chongqing Bovax)
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious Diseases
Active Indication
Enterovirus 71 infectionHand, Foot and Mouth Disease
Inactive Indication-
Originator Organization
Chongqing Bovax Biopharmaceutical Co., Ltd.Chongqing Bovax Biopharmaceutical Co., Ltd.
Active Organization
Chongqing Bovax Biopharmaceutical Co., Ltd.Chongqing Bovax Biopharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Enterovirus Type 71 Vaccine(Hansenula Polymorpha)(Chongqing Bovax)
CTR20222612
/ CompletedPhase 1
随机、盲法、安慰剂和阳性对照评估重组肠道病毒71型疫苗（汉逊酵母）接种于6月龄~17周岁以及18周岁及以上中国健康人群中的安全性和初步免疫原性的I期临床试验
[Translation] A randomized, blinded, placebo- and active-controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of a recombinant enterovirus 71 vaccine (Hansenella) in healthy Chinese subjects aged 6 months to 17 years and 18 years and older
100 Clinical Results associated with Enterovirus Type 71 Vaccine(Hansenula Polymorpha)(Chongqing Bovax)
Login to view more data
100 Translational Medicine associated with Enterovirus Type 71 Vaccine(Hansenula Polymorpha)(Chongqing Bovax)
Login to view more data
100 Patents (Medical) associated with Enterovirus Type 71 Vaccine(Hansenula Polymorpha)(Chongqing Bovax)
Login to view more data
100 Deals associated with Enterovirus Type 71 Vaccine(Hansenula Polymorpha)(Chongqing Bovax)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Enterovirus 71 infectionPhase 1
China
Chongqing Bovax Biopharmaceutical Co., Ltd.Chongqing Bovax Biopharmaceutical Co., Ltd.
23 Oct 2022
Hand, Foot and Mouth DiseasePhase 1
China
Chongqing Bovax Biopharmaceutical Co., Ltd.Chongqing Bovax Biopharmaceutical Co., Ltd.
23 Oct 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free